ROST
60
3
HIG
48
5
ICE
53
5
ZBH
69
15
DG
14
6
HAL
40
11
HSIC
42
2
XEL
48
11
ORLY
48
3
ALL
37
3
ESS
44
5
CLX
65
2
EQR
33
6
UNP
38
5
PFG
27
7
SBUX
29
-2
GS
65
16
VRSN
59
4
KEY
24
2
PDCO
77
3
ROST
60
3
HIG
48
5
ICE
53
5
ZBH
69
15
DG
14
6
HAL
40
11
HSIC
42
2
XEL
48
11
ORLY
48
3
ALL
37
3
ESS
44
5
CLX
65
2
EQR
33
6
UNP
38
5
PFG
27
7
SBUX
29
-2
GS
65
16
VRSN
59
4
KEY
24
2
PDCO
77
3
Financhill
Back

Medpace Holdings Quote, Financials, Valuation and Earnings

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45

MEDP
Medpace Holdings

Last Price:
$337.01
Seasonality Move:
-3.01%

7 Day Trial

ALL ACCESS PASS

$ 7

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here

Medpace Holdings Price Quote

$337.01
-0.56 (0.56%)
(Updated: December 21, 2024 at 5:36 AM ET)

Medpace Holdings Key Stats

Sell
45
Medpace Holdings (MEDP) is a Sell
Day range:
$334.00 - $342.50
52-week range:
$277.72 - $459.77
Dividend yield:
0%
P/E ratio:
38.01
P/S ratio:
5.22
P/B ratio:
11.9%
Volume:
608.9K
Avg. volume:
333.4K
1-year change:
11.36%
Market cap:
$10.5B
Revenue:
$1.9B
EPS:
$11.42

How Much Does Medpace Holdings Make?

Data Unavailable

Is Medpace Holdings Growing As A Company?

Data Unavailable

Medpace Holdings Stock Price Performance

  • Did Medpace Holdings Stock Go Up Last Month?
    Medpace Holdings share price went up by 3.52% last month
  • Did MEDP's Share Price Rise Over The Last Year?
    MEDP share price rose by 11.36% over the past 1 year

What Is Medpace Holdings 52-Week High & Low?

Medpace Holdings Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Medpace Holdings?

Data Unavailable

Is Medpace Holdings Cash Flow Positive?

Data Unavailable

Medpace Holdings Return On Invested Capital

Data Unavailable

Medpace Holdings Earnings Date & Stock Price

Medpace Holdings Competitors

  • Who Are Medpace Holdings's Competitors?
    Below is a list of companies who compete with Medpace Holdings or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • CEL-SCI Corp (CVM)
    • Fortrea Holdings Inc (FTRE)
    • IGC Pharma Inc (IGC)
    • IQVIA Holdings Inc (IQV)

Medpace Holdings Dividend Yield

Data Unavailable

Medpace Holdings Analyst Estimates

YoY Growth Past Surprise
EPS: 35.59% 5.15%
Revenue: 8.29% -1.42%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 347.92
Upside from Last Price: 3.07%

Major Shareholders

Data Unavailable